Want to join the conversation?
Biotechnology company $BIIB reported a 13% growth in 2Q16 earnings driven by revenue strength coupled with management of expenses as well as solid performance across its commercial business. Net income rose to $1.05Bil or $4.79 per share from $927MM or $3.93 per share last year. Non-GAAP EPS increased to $5.21 from $4.22.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?